No Data
No Data
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and
Edwards Lifesciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/16/2024 22.22% Truist Securities $105 → $110 Maintains Buy 07/10/2024 17.78% Citigroup $105 → $106
Truist Financial Maintains Edwards Lifesciences(EW.US) With Buy Rating, Announces Target Price $110
Truist Financial analyst Richard Newitter maintains $Edwards Lifesciences(EW.US)$ with a buy rating, and sets the target price at $110.According to TipRanks data, the analyst has a success rate of 58.
Express News | Edwards Lifesciences Corp : Truist Securities Raises Target Price to $110 From $105
Truist Raises Price Target on Edwards Lifesciences to $110 From $105, Maintains Buy Rating
06:57 AM EDT, 07/16/2024 (MT Newswires) -- Truist Raises Price Target on Edwards Lifesciences to $110 From $105, Maintains Buy RatingPrice: 89.85, Change: +0.35, Percent Change: +0.39
Edwards Lifesciences Buys Mitral Valve Business Innovalve in $300m Deal